Clinical Trials on Registration of a Complaint Following the Terrorist Attack of 14 July 2016 in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
- Sudimplant SAS - Groupe TBR
- Iyad Naeem Muhammad, PhD
- Korea Otsuka International Asia Arab
- United States Department of Defense (DOD)
- S-Biotek Holding ApS
- Plethora Solutions Ltd
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Oblikue Consulting
- Foshan Sanshui District People's Hospital
- Arsha Vidya Tirtha
- Rivierduinen, Centre for Personality disorders Jelgersma
- Eurotrials Brasil Consultores Cientificos Ltda
- Cardiovascular Center Dedinje, Belgrade, Serbia
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Paulo Sérgio Gomes Nogueira Borges
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Julian Taylor Green
- Lilly PharmaceuticalCompany
- Gunkang Pharmaceuticals, Inc
- University of Applied Sciences Jena
- View Full List
Medical Conditions
- Malaria,Falciparum
- Testicular Teratoma
- Hypothermia Following Anesthesia, Sequela
- Advance Directive Completion
- Anemia Acute
- Visual Attention Span Deficit
- Chemotherapy-Induced Neutropenia
- Immunologically-induced Lung Disease
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Gray Platelet Syndrome
- Huntington Chorea
- Thyroid and Parathyroid Surgery
- Blepharospasm of Both Eyelids
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Puberty, Delayed
- Brain Tumor, Primary
- Vibration; Exposure
- Serum Albumin Low
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Deformity Flexion
- View Full List
Drug Interventions
- Pemetrexed
- Vosaroxin
- Mineralocorticoid receptor antagonist
- Oxycodone
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Pegfilgrastim
- MMV390048 120mg
- Cytisine
- Cyanoacrylate
- Bimatoprost 0.03% eye drops
- Rovalpituzumab tesirine
- Furmonertinib 160 mg
- Acalabrutinib in combination with VR
- Celecoxib
- F520
- Standard medical therapy
- Sorafenib
- ABY-035 i.v.
- S-Adenosyl-Methionine
- Ebselen
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Armenia
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Greece
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Italy
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Mexico
- Contract Research Organizations in Tanzania
- Contract Research Organizations in Venezuela
- CRO list by country